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Abstract
Purpose: Increased knowledge of the prevalence of various craniofacial anomalies and their associated risks for hearing
loss can help (a) guide the development of evidence-based practice regarding detection and documentation of risk factors
at birth, and (b) health care professionals make appropriate recommendations for follow-up testing and monitoring.
Method: Records were reviewed for 39,813 infants born at two hospitals between January 1, 2014 and December 31,
2019 to determine the association between the presence of craniofacial anomalies and newborn hearing screening fail
rates. Prevalence of confirmed hearing loss for infants born with and without risk factors were also examined. Additionally,
surveys were sent to state EHDI programs and newborn hearing screening program coordinators across the United States
to determine how facilities document risk factors for hearing loss, specifically craniofacial anomalies.
Conclusions: Study outcomes revealed four primary conclusions: (a) Infants with craniofacial anomalies are at a greater
risk for failing their newborn hearing screening; (b) There is a need to better delineate craniofacial anomaly risk factors
into subgroups; (c) Follow-up audiologic evaluations are not warranted for infants with preauricular sinuses/tags and;
(d) A universal protocol needs to be developed for recording risk factors for all infants and for training newborn hearing
screening (NBHS) staff to identify such risk factors.
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Universal newborn hearing screening (NBHS) programs
have been established to provide the early detection of,
as well as guide intervention for, hearing loss in newborns
(Joint Committee on Infant Hearing [JCIH], 2019). One
of the primary goals of NBHS is to “maximize linguistic
competence and literacy development for children who are
deaf or hard of hearing” since they are more likely to fall
behind their hearing peers in communication, cognition,
reading, and social-emotional development (p. 898, JCIH,
2007) without early intervention. The 1-3-6 Early Hearing
Detection and Intervention (EHDI) model recommends
that all infants be screened by one month of age, identified
with hearing loss by three months of age, and receive
intervention by six months of age (JCIH, 2019) so that they
have the best chance to reach their potential.
The Joint Committee on Infant Hearing (JCIH) currently
identifies 12 risk indicators that are associated with

congenital, late onset, or progressive hearing loss in
newborns: family history of childhood hearing loss,
neonatal intensive care unit (NICU) stay of greater than
five days, hyperbilirubinemia with exchange transfusion,
treatment with ototoxic medications for greater than five
days, asphyxia or hypoxic ischemic encephalopathy,
extracorporeal membrane oxygenation (ECMO), in-utero
infections, craniofacial conditions and physical conditions
associated with hearing loss, syndromes associated with
hearing loss, perinatal or postnatal bacterial and/or viral
meningitis or encephalitis, events associated with hearing
loss, and family/caregiver concern. It is imperative that
infants identified as having one or more of these risk
factors be closely monitored and re-evaluated routinely
to rule out later onset or progressive sensorineural,
mixed, or conductive hearing loss, regardless of NBHS
screening results. The specific timing and number of these
evaluations vary for each individual based on the identified
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risk factor(s) and clinical judgment of the audiologist and/
or primary care provider. It is recommended, however, that
infants who have a craniofacial anomaly (CFA), regardless
of the type, be re-evaluated by nine months of age (JCIH,
2019). It is the responsibility of the pediatrician or primary
care provider (also known as the medical home) to monitor
these risk indicators to ensure that audiological evaluations
are completed as recommended (JCIH, 2019).
Research suggests that there is a lack of knowledge
among healthcare professionals as to which of the
aforementioned risk factors are “discoverable, predictive,
and useful” (Karace et al., 2014, p. 262). This lack of
knowledge lessens the effectiveness of initial screening
and the impact of the JCIH guidelines, as well as the
occurrence of follow-up testing, because medical
professionals and newborn hearing staff are often unable
to recognize the need for follow-up hearing testing when
a specified risk factor is present (Hutt & Rhodes, 2008).
Increasing knowledge about the various risk factors
and their associated risk for hearing loss will help guide
evidence-based practice and policy development regarding
the detection and intervention of hearing loss in infants
(Hutt & Rhodes, 2008).
The present study addresses NBHS outcomes for infants
who have a documented CFA. CFAs are defined as
those that include microtia/atresia, ear dysplasia, oral
facial clefting, white forelock, microphthalmia, congenital
microcephaly, congenital or acquired hydrocephalus and/
or temporal bone abnormalities, and skull malformations
(JCIH, 2019). CFAs are also found within certain
syndromes such as: Trisomy 21, Treacher Collins
syndrome, Waardenburg syndrome, CHARGE Association,
Crouzon disease, Klippel-Feil syndrome, DiGeorge
syndrome, Goldenhar syndrome and Pierre Robin
syndrome (Greydanus et al., 2007). There is substantial
evidence that the CFA risk factor group yields the highest
prevalence of hearing loss in infants and children, however,
the prevalence of hearing loss associated with each
specific craniofacial disorder has not been consistently
reported in the literature (Appelbaum et al., 2018; ConeWesson et al., 2000; Dumanch et al., 2017; Yelverton et al.,
2013). For example, the published prevalence of hearing
loss in cleft lip and cleft palate ranges from 26% to 82%
(Chen et al., 2008; Viswanathan, Vidler, & Richard, 2008)
and .3% to 18% for preauricular sinuses and tags (Firat et
al., 2008; Kankkunen & Thiringer, 1987; Roth et al., 2008).
These variations appear to be due to different methods for
ascertaining the presence of hearing loss and risk factors
including newborn hearing screenings, retrospective
review of medical charts, and auditory brainstem response
threshold assessments. There is also insufficient data on
prevalence figures for other CFAs such as malformed ears,
microtia, and skull malformations. Consequently, the exact
association between each specific CFA and hearing loss
risk at birth is unknown. Risk factors are only as “useful
as their predictive power” (Karace et al., 2014, p. 262);
therefore, it is imperative to determine the associated risk
for hearing loss at birth for each of these disorders. In turn,
this could lead to the development of effective follow-up

guidelines and recommendations appropriate to each CFA.
Since not every CFA has the same incidence/prevalence
of congenital, progressive, or late-onset hearing loss, this
clarification is crucial.
Aside from a lack of knowledge concerning the prevalence
of each specific CFA and their respective contributions
to NBHS fail rates, there is also a lack of documentation
in state databases regarding risk factor information from
hospitals in the country (Hutt & Rhodes, 2008; White,
2014). It is a guideline, not a requirement, to record risk
factors in the NBHS databases (JCIH, 2019). Current risk
factor registers are designed to ensure that newborn infants
who need evaluation and follow-up are identified, however,
these registers often lack specific/universal criteria, are
under-utilized, and NBHS programs likely underreport
various risk factors associated with hearing loss in their
databases (Hutt & Rhodes, 2008). Without documentation
of risk factors, healthcare providers are unable to ensure
efficient, effective, timely and appropriate follow-up
recommendations. For example, in a study examining birth
certificate records, Purcell and colleagues (2018) “found
that only 39% of children with cleft palates were correctly
identified as having a craniofacial risk factor [for hearing
loss] at the time of hearing screening”, which ultimately
led to a delayed diagnosis of hearing loss for many of
these children (p. 26). That is, many of these children may
have initially passed their newborn hearing screening but
developed progressive/late onset hearing loss that was not
caught. This delayed diagnosis of hearing loss may have
been due to a lack of follow-up and monitoring for these
children. Determining which CFAs result in a child having
a greater risk for childhood hearing loss, in turn, ensures
adequate and appropriate follow-up and intervention.
The following were the specific research questions
examined in this study:
1. What is the association between the presence of
CFAs (as a general category) and NBHS fail rates for
infants born at two hospitals, Adventist HealthCare
Shady Grove Medical Center (AHC SGMC) and
Adventist HealthCare White Oak Medical Center
(AHC WOMC) in the Greater DC area?
2. What is the association between specific CFAs and
NBHS fail rates for infants born at AHC SGMC and
AHC WOMC?
3. What is the prevalence of confirmed hearing loss
(conductive, mixed, or, sensorineural) for infants
born at AHC SGMC and AHC WOMC who failed the
NBHS, with or without risk factors?
4. What information does each state’s EHDI program
require from individual screening programs as
it pertains to the documentation of CFAs? How
successful are the EHDI programs in obtaining such
information?
5. How well are NBHS programs across the country
recording and documenting information about the
presence of risk factors for hearing loss and CFAs?
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Method
This study was approved by the Institutional Review
Boards at Adventist HealthCare (2019-29) and Gallaudet
University (Legacy-IRB-FY20-04). Descriptive statistics
were used to report the outcomes obtained from this study.
Participation
To answer the first three research questions, records were
reviewed for 39,813 infants born at AHC SGMC and AHC
WOMC over a six-year period between January 1, 2014
and December 31, 2019; reporting requirements remained
consistent during this time frame. Both hospitals provide
newborn hearing screening services, but not diagnostic
evaluations.
The following data were retrieved from the Maryland
Early Hearing Detection and Intervention (MD EHDI)
program database, also known as OZ: (a) risk factor(s)
present for hearing loss, (b) NBHS outcomes, (c)
outpatient screening outcomes (if applicable and if
available), and (d) diagnostic outcomes (if applicable and
if available). If specific CFA information was missing, or if
confirmation of OZ was needed, the hospitals’ electronic
medical records were subsequently reviewed. A review
of both hospitals’ NBHS program department records
was also conducted to obtain information about specific
CFAs for each infant, and when available, to clarify any
discrepancies in OZ, as well as identify any risk factors
for hearing loss that were incorrectly documented in OZ.
Incorrect documentation could include omissions of risk
factors in the state database and inaccurately recorded
results in the hospital records.
Both hospitals in this study used a two-step screening
protocol. All babies in the Well-Baby Nursery (WBN)
without a risk factor for hearing loss were tested using
either transient otoacoustic emissions (TEOAE) or
distortion product otoacoustic emissions (DPOAE). If an
infant failed the initial screening, a second OAE test was
performed the next day. If the infant failed the second
OAE, then an automated auditory brainstem response
(AABR) screening was performed. All babies born
with a risk factor for hearing loss (with the exception of
preauricular pits and preauricular tags) or treated in the
NICU were screened using AABR. If the infant failed the
initial AABR, a subsequent and final AABR was performed,
time permitting.
All OAE and AABR equipment were calibrated annually
according to manufacturers’ guidelines. AHC WOMC
uses the Otodynamics Otoport for portable, bedside
TEOAE screening, while AHC SGMC uses the Maico
EroScan DPOAE for bedside DPOAE screening. For
AABR and additional TEOAE screening, both hospitals
use the Intelligent Hearing Systems (IHS) Smart Screener
Plus.
To answer research questions 4 and 5, two separate
surveys were distributed to: (a) State EHDI leaders
and (b) NBHS program coordinators throughout the
United States. The EHDI state leader survey can be
found in Appendix A, while the NBHS Coordinator

Survey can be found in Appendix B. Participants for
both surveys signed an informed consent form and
remain anonymous. The surveys were designed to
be completed easily and quickly by participants using
multiple choice, multi-answer, yes/no, and openended questions. Sample surveys were piloted with
two independent audiologists (one state leader and
one NBHS program coordinator) to ensure ease of
completion, address any ambiguities, and determine the
time needed to complete the surveys.
Surveys were designed and posted on a secure online
platform (REDCap), where participants were able to
access and complete the survey anonymously. Requests
for participation for each survey were distributed
electronically in three ways. The first was through two
professional audiology groups (American SpeechLanguage-Hearing Association and the American
Academy of Audiology). The second was through posting
on two audiology Facebook pages (Audiology Antics and
Anecdotes- for professionals only, and Audiology Happy
Hour). The last was by distributing two different emails
to all state EHDI leaders. The first email requested their
participation in the State EHDI Leader Survey; this email
included a link to the REDCap survey. The second email
requested that they forward via email a description of,
and a link to, the NBHS Coordinator Survey to NBHS
coordinators in their state. To complete the NBHS
Coordinator Survey, the participants had to currently
be in charge of a NBHS program at a hospital, birthing
center, NICU or other facility providing NBHS. A followup email was distributed to EHDI state leaders four
weeks after the first email was sent if they had not yet
completed the survey.
For the EHDI state leader survey, data from 13 states
was received. Participating states are not identified in
this paper to protect the privacy of those who responded.
A total of 90 participants responded to the NBHS
program coordinator study with a total of 18 states being
represented across various regions of the United States;
one participant did not report in which state they practiced.
Descriptive statistics were used to analyze responses from
both surveys.
Results
Presence of Any CFA and NBHS Fail Rates
There were 39,813 infants born at AHC SGMC and
AHC WOMC between January 1, 2014 and December
31, 2019. A total of 2.05% (n = 817) of all infants born
during this period had a CFA that was documented in the
department’s paper records and/or hospital electronic
medical records. The hearing screening fail rate for those
identified with any CFA was 4.41% (n = 36), compared to
the overall fail rate of 0.74% (n = 293) for all newborns,
with or without a risk factor for hearing loss. The majority
of the 293 infants who failed the NBHS had no risk factors
for hearing loss (64.51%, n = 189), while 12.29% (n = 36)
had a CFA, and 23.20% (n = 68) had other risk factors for
hearing loss.
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Association Between Specific CFAs and NBHS Fail Rates
As described earlier, a total of 817 of the 39,813 infants
seen for a newborn hearing screening were identified
as having a CFA. This group of infants was further
categorized based on the specific anomalies present. The
syndromes (associated with hearing loss) identified in our
population were: Trisomy 13, Trisomy 18, 13q syndrome,
Osteogenesis Imperfecta, Achondroplasia, Waardenburg
syndrome, Goldenhaar syndrome, Pallister Killian
syndrome, Beckwith Wiedemann syndrome, Turners
syndrome, Albinism, and Cornelia de Lange syndrome.
Other CFAs present included preauricular sinuses/tags,
atresia/microtia, malformed ears, skull malformations, and
cleft lip/palate. The prevalence for each of these specific
CFAs and their associated NBHS fail rates are reported in
Table 1. It is important to also note that two infants in the
cleft lip/palate category were counted in two categories;
once in the skull malformation category and once in the
syndrome category.
Table 1
Prevalence of Specific Craniofacial Anomalies (CFAs)
at Birth and the Associated Newborn Hearing Screening
(NBHS) Fail Rate
Category of CFA

Syndrome associated
with hearing loss

Total Percentage NBHS Fail Rate
of CFA
(n = 36)
(n = 819)a
% (n)
% (n)
9.4% (77)

18.18% (14)

82.25% (672)

0.74% (5)

1.47% (12)

100% (12)

Malformed Ears, other

1.35% (11)

36.36% (4)

Skull Malformations

0.61% (5)

20% (1)

Cleft Lip/Palate

4.16% (34)

5.8% (2)a

Other

0.98% (8)

0.00% (0)

Ear Sinuses/Tags
Atresia/Microtia

b

includes two babies with other CFAs: Syndrome & Skull
Malformations
b
babies were tested with Automated Auditory Brainstem
Response only
a

Considering that 82.25% of babies with a CFA had
preauricular sinuses and tags, this category was further
analyzed. Table 2 shows the prevalence of, and the fail
rate for, each sub-category of preauricular sinuses and
tags. Regardless of whether a sinus and/or tag was
unilateral or bilateral, the NBHS fail rate was less than 1%.
In reviewing the records of infants with a CFA who had
failed their NBHS (n = 36), 58.33% (n = 21) did not exhibit
any additional risk factors, while 41.66% (n = 15) did have
an additional risk factor. Of the latter, a total of 22.22%
(n = 8) of these infants spent greater than five days in
the NICU; 11.11% (n = 4) had two other risk factors (e.g.
NICU stay greater than five days and ototoxic medications
greater than five days; ECMO and a NICU stay greater
than five days); and 8.33% (n = 3) had three other risk
factors present (cytomegalovirus, NICU stay greater than
five days, and ototoxic medications greater than five

days; ototoxic medications greater than five days, NICU
stay greater than five days, and ventilator; or, ototoxic
medications greater than five days, NICU stay greater than
five days, and loop diuretics).
Table 2
Prevalence of Unilateral vs Bilateral Preauricular Sinuses/
Tags and the Associated Fail Rate
Prevalence (n)

NBHS Fail
Rate (n)

Unilateral Preauricular Tags

30.95% (208)

0.96% (2)

Unilateral Preauricular
Sinuses

51.34% (345)

0.29% (1)

Bilateral Preauricular Tags

2.68% (18)

0.00% (0)

Bilateral Preauricular
Sinuses

14.43% (97)

0.21% (2)

0.61% (4)

0.00% (0)

Category of CFA

Preauricular Sinuses and
Preauricular Tags

Note. NBHS = Newborn Hearing Screening; CFA = Craniofacial
Anomaly.

Prevalence of Confirmed Hearing Loss for Infants
Who Failed the Newborn Hearing Screening, With or
Without Risk Factors
Data from the outpatient hearing screenings, as well
as diagnostic outcomes for infants who had failed their
newborn hearing screening, were accessed through
OZ. For the 293 infants who failed the newborn hearing
screening, 70.99% (n = 208) were referred for a follow up
screening, and were seen either internally or at an outside
clinic. Of these infants, 69.23% (n = 144) passed the
rescreening, 14.90% (n = 31) failed the rescreening, and
15.87% (n = 33) were lost to follow-up. The 31 infants who
failed their rescreening were referred to a local children’s
hospital for diagnostic testing. Those results revealed that
43.75% (n = 13) infants had normal hearing acuity, 46.88%
(n =15) were diagnosed with hearing loss, and 9.38% (n
= 3) were lost to follow-up. Most of the infants who failed
their initial screening and had a risk factor for hearing loss
(n = 85) were referred directly to a pediatric audiologist for
diagnostic evaluation. Hearing loss was identified in 48.23%
(n = 41) of these infants, while normal hearing acuity was
found in 30% (n = 26), and 21.12% (n = 18) were lost to
follow-up. Note that the definition of normal hearing and
hearing loss, as well as the degree and type of hearing loss,
were not provided in OZ, so parameters are unknown.
A risk factor was present in 76.79% (n = 43) of the 56 infants
who were diagnosed with hearing loss, while no risk factors
were present in 23.21% (n = 13). A CFA was identified in
33.93% (n = 19) of the infants diagnosed with hearing loss;
that is, 19 of the total number of infants identified with a
risk factor and subsequently identified with a hearing loss
had a CFA (i.e., 19/43 = 44.2%). Of these infants, unilateral
hearing loss was found in 63.16% (n = 12), while 36.84% (n
= 7) were diagnosed with bilateral hearing loss. For those
infants who did not have a CFA (66.07%; n = 37), a unilateral
hearing loss was diagnosed in 18.92% (n = 7) and a bilateral
hearing loss was diagnosed in 81.08% (n = 30).
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State EHDI Program Survey Results
As previously described, a total of 13 EHDI state leaders
(22.03%) responded to the EHDI State Leader Survey.
Results from this survey are presented in Table 3; the
numbering beside each question corresponds to the
specific question found in Appendix A.
Table 3
Results from the Early Hearing Detection and Intervention
State Leader Survey
Survey Questions from EHDI
State Leaders

Yes

No

3) Does your state mandate newborn
hearing screenings in all, or most,
birthing facilities?

84.62%
(n = 11)

15.38%
(n = 2)

5) Are facilities required to document
specific risk factors in the state
EHDI database?

46.15%
(n = 6)

53.85%
(n = 7)

8) If a CFA is reported, do you
request additional information
about the specific CFA from
program coordinators?

23.08%
(n = 3)

76.92%
(n = 10)

9) Are you satisfied with the
documentation completed by the
facilities in your state regarding the
risk factors for hearing loss?

38.36%
(n = 5)

61.54%
(n = 8)

Yes, most
Some
No, most
facilities do facilities do, facilities do
some do not
not

4) Do facilities in your
state submit newborn
hearing screening data
for all infants born?

100%
(n = 13)

0%
(n = 0)

0%
(n = 0)

6) Do facilities in your
state submit risk
factor information, as
required?

15.38%
(n = 2)

61.54%
(n = 8)

23.08%
(n = 3)

7) If an infant is identified
as having a CFA, do
facilities in your state
record the specific
anomaly present?

38.46%
(n = 5)

38.46%
(n = 5)

23.08%
(n = 3)

Note. EHDI = Early Hearing Detection and Intervention; CFA =
Craniofacial Anomaly.

Multiple state leaders had suggestions for NBHS
programs in response to question #10 “Do you have any
suggestions for how to improve the recording, reporting or
follow-up process for infants with risk factors for hearing
loss, including infants with craniofacial anomalies?” Top
responses included (a) involve primary care physicians,
(b) increase the education and training for staff involved in
NBHS programs, (c) include a system that automatically
links data from the hospital/facility’s electronic health records
system to the state database, and (d) utilize the Centers for
Disease Control and Prevention Birth Defects Registry.
NBHS Program Coordinator Survey Results
A total of 90 newborn hearing screening program coordinators
responded to our survey. Appendix C1 demonstrates a

breakdown of the professions of the program coordinators,
Appendix C2 shows the professions of those conducting the
newborn hearing screenings, and the breakdown of states in
which the respondents practice is shown in Appendix C3.
When surveyed, 75.56% (n = 68) of the program
coordinators reported that information regarding risk
factors for hearing loss were collected at their facility. This
information was collected in multiple ways (Question 9
from survey): by asking hospital staff, 28.89% (n = 26);
checking infant medical records, 62.22% (n = 56); asking
the infant’s mother case history questions, 60.00% (n
= 54); and collecting risk factor information by another
method, 3.90% (n = 3).
In some facilities, information concerning risk factor
information was obtained from multiple sources, resulting
in the total percentage exceeding 100%.
Table 4 displays responses to other questions
(corresponding to the numbered questions in Appendix
B) that were posed to the NBHS program coordinators. In
addition to the information contained in Table 4, nine of the
90 NBHS coordinators (10%) also reported their newborn
hearing screening fail rate for infants with CFAs.
Table 4
Results from the Newborn Hearing Screening Program
Coordinator Survey
Survey Questions from Program
Coordinator Survey

Yes

No

6) Does your facility employ
audiologists to oversee the
program?

24.44%
(n = 22)

75.56%
(n = 68)

7) Is your staff trained to identify the
different risk factors associated with
childhood hearing loss?

83.33%
(n = 75)

16.67%
(n = 15)

8) Is information regarding risk
factors for childhood hearing loss
collected prior to or following each
screening? (Questions 10 through
13 were recorded only if answered
‘yes’ for question 8)

75.56%
(n = 68)

24.44%
(n = 22)

10) Does your program record the
type of risk factor(s) in the hospital
medical records

77.94%
(n = 53)

22.06%
(n = 15)

11) If an infant is identified as having
a risk factor, does your program
report the information to the state
EHDI program?

76.47%
(n = 52)

23.53%
(n = 16)

12) If an infant is identified with a CFA,
does your program record the
specific type of CFA present?

76.47%
(n = 52)

23.53%
(n = 16)

13) Do you report the specific CFA to
the state EHDI program?

69.23%
(n = 36)

30.77%
(n = 16)

14) Do you feel as though you are
getting enough guidance from your
state EHDI program on how to
document and report risk factors?

58.89%
(n = 53)

41.11%
(n = 37)

Note. EHDI = Early Hearing Detection and Intervention; CFA =
Craniofacial Anomaly.
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Discussion
The overall newborn hearing screening fail rate measured
at the two study hospitals (0.74%) was lower than the
national fail rate of 4% (ASHA, n.d.). This lower fail rate
may be attributed to the two-step screening protocol used
at these two hospitals, as described in the Method section.
A failed OAE followed by an AABR may reduce false
positive rates since the AABR is less sensitive to vernix
or debris in the ear canal which is a significant cause of
failed screenings (American Speech-Language-Hearing
Association [AHSA], n.d.). Without the follow-up AABR,
there would be a much higher false-positive rate. Reducing
false-positive rates (a) allows infants at risk to be more
accurately targeted for follow-up testing, and (b) reduces
the wait time and workload for pediatric audiologists by
reducing the demand for diagnostic testing.
The hearing screening fail rate for those identified with a
CFA (4.4%) is six times higher than the overall fail rate of
0.74% for all newborns. This supports the current JCIH
inclusion of CFA on the list of risk factors for hearing
loss. In examining the NBHS fail rates for the seven
CFA subgroups identified in this study, the fail rates vary
greatly, from 0% to 100%. This suggests the need to
further delineate the craniofacial risk factor category into
subgroups, with follow-up evaluation recommendations
based on the specific CFA, rather than CFA category as
a whole. For example, an infant with only a preauricular
sinus (.25% fail rate) should not receive the same
follow-up recommendations as an infant with microtia/
atresia (100% fail rate). Currently, the JCIH recommends
audiological follow-up/re-evaluation by nine months of
age, regardless of the type of CFA present (JCIH, 2019).
However, appropriate follow-up evaluations should be
recommended based on the specific needs of an infant
to ensure that the infant has the best opportunity for early
detection and intervention or plan for monitoring in case of
a possible progressive or late-onset hearing loss. These
findings suggest that JCIH should consider refining their
list of risk factors for hearing loss to include separate
recommendations for the specific CFAs.
Our screening fail rate of 0.74% for infants with preauricular
sinuses and/or tags, in the absence of other physical
findings, indicates that routine audiological reevaluation
is not warranted for this population. After subdividing
the preauricular sinuses/tag group into more specific
sub-groups, we determined that infants with either a
preauricular sinus or tag, whether unilateral or bilateral,
exhibited similar NBHS fail rates (i.e., all less than 1%). A
progressive hearing loss would not be expected if these
were the only anomalies, however, it is recommended
that these anomalies continue to be documented since
they can be associated with various syndromes that do
have a higher likelihood of hearing loss, such as Trisomy
21, Treacher Collins syndrome, CHARGE Association,
Waardenburg Syndrome, Crouzon disease, and so on
(Greydanus et al., 2007). Accurate documentation of
preauricular sinuses and preauricular tags will assist the
medical home in monitoring for any additional signs and/

or symptoms associated with such syndromes. Research
suggests that skin tags can also be associated with
maternal diabetes and may not be related to any ear issues
at all; therefore, it is important to obtain a mother’s medical
history to determine if maternal diabetes is a possible
underlying cause for the preauricular tags (Grix et al., 1982;
Johnson, Fineman & Opitz, 1982; Sait et al., 2019).
Based on the findings from the two hospitals, of the
56 infants subsequently diagnosed with a hearing loss
following their birth screening, infants with a risk factor for
hearing loss (43/56) were 3.3 times more likely than infants
without a risk factor (13/56) to be diagnosed with a hearing
loss following their birth screening. And, of the infants with
a risk factor(s) that were identified with a hearing loss, 19 of
43 (44.2%) of them had a CFA. This data provides strong
evidence of the need for follow-up evaluations for all infants
with a CFA, except for infants with preauricular sinuses and
tags due to the low prevalence of NBHS fail rate.
Multiple errors were discovered when comparing
the hospital records to OZ. Information pertaining to
preauricular sinuses and tags that had been documented
appropriately in the hospital records was omitted 154 times
in the state database. In addition, one infant’s NBHS result
was entered incorrectly into the state database as having
passed the NBHS when, in fact, the infant had actually
failed in both ears. When errors were discovered, they
were corrected in the database. The two NBHS programs
in this study are managed by audiologists and have a
well-developed protocol for documenting and recording
risk factors, yet, errors still occurred. Programs without
such audiology oversight and thorough protocols could
potentially have even more documentation errors.
Based on the survey findings, it appears that a majority
of the NBHS program coordinators are documenting and
reporting the presence of risk factors in their hospital
medical records (see Table 4), however, the majority of
the EDHI State Leaders indicated that newborn hearing
screening programs were failing to document this
information in their state EHDI records (see Table 3). In
addition, responses suggest that close to 2/3 of the EHDI
NBHS state leaders who responded (61.54%; n = 8) were
not satisfied with how facilities in their state document
and record risk factors for hearing loss. Currently, JCIH
has a list of guidelines that each newborn hearing
screening program should follow. Because the guidelines
are suggestions, not policy, and because each program
documents and reports risk factors differently, measuring
prevalence figures for hearing loss risk is a challenge. If
the findings from this study are indeed reflective of most
NBHS programs, then these guidelines should become
protocol. Having a universal protocol (including training
of staff) would reduce the chances of NBHS programs
overlooking risk factors, which would increase appropriate
referrals for diagnostic testing and early intervention.
Results from the NBHS Coordinator Survey also
indicate that some programs (16.67%; n = 15) do not
train their newborn hearing screeners to identify the
different risk factors for hearing loss. While conducting
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the hospital records review for this study, it was noted
that pediatricians at the hospitals often neglected to
document the presence of preauricular sinuses and tags
as well as other ear malformations during the newborn’s
physical exam, and that our trained hearing screeners
were often the ones to identify the presence of such
abnormalities. Correctly and accurately identifying infants
with risk factors for hearing loss, such as CFAs, helps
guide referrals for follow up care. In addition to detecting
physical anomalies associated with possible hearing
loss, newborn hearing screening staff should also be
trained to review hospital records and question parents
to identify other possible risk factors for hearing loss,
including a family history of childhood hearing loss. The
NBHS Program Coordinator survey suggests that roughly
a quarter of newborn hearing screening programs do not
collect general risk factor information, as recommended
by JCIH guidelines. Additionally, 31% of the newborn
hearing screening programs do not report CFAs to their
state database (see Table 4). This information is vital
because without such information, infants with these
risk factors may not receive the appropriate follow-up
recommendations and referrals.
Responses from this survey also revealed that 75%
(n = 68/90) of facilities do not employ an audiologist to
oversee the newborn hearing screening program. Having
audiologist oversight, as recommended in the new JCIH
2019 guidelines, would increase the probability that staff
are trained properly to identify risk factors for hearing loss,
and ensure appropriate referrals and recommendations. In
addition to having audiologist oversight, it is important for
NHBS programs to identify the newborn’s medical home,
and communicate the hearing screening results with them,
if the infant failed their screening (ASHA, n.d.).
Approximately 40% (n = 37) of the NBHS Program
Coordinators reported that they did not feel they had
received enough guidance from their state EHDI program
as to how they should document and record risk factors
for hearing loss. EHDI programs are designed to maintain
a coordinated, statewide screening and referral system
for those infants who do not pass the newborn hearing
screening. Without strong guidance from their state EHDI
program, infants are at risk for not receiving adequate and
appropriate follow-up care (EHDI, 2020). Thus, based on
the findings in this study, JCIH should consider developing
a universal newborn hearing screening program protocol
that all birthing facilities must follow.
Study Limitations
The first limitation of this study concerns the number of
responses from NBHS program coordinators and state
leaders of EDHI programs. It is hard to generalize our
conclusions with responses from only 13 state leaders
and 90 program coordinators from 18 different states.
Increased participation would have allowed for a better
representation of how NBHS programs across the country
are recording and documenting risk factors for hearing
loss.

A second limitation of the study was that the population
from the two hospitals lacked geographic diversity. Both
hospitals are located in suburban neighborhoods outside
of Washington, DC. It is possible that the incidence of
CFAs and the screening/documentation protocols may
differ from birthing centers in other regions. Therefore,
additional data are needed from birthing centers
throughout the United States of America before our
findings can be generalized.
A third limitation is that the technicians who performed
the newborn hearing screenings could have omitted
or incorrectly documented risk factors for hearing loss,
particularly preauricular sinuses and preauricular tags, as
well as other ear malformations. If these risk factors were
missed or entered incorrectly, then the hearing screening
fail rate relative to the possible risk factors and CFA type
could be inaccurately represented.
A fourth limitation of this study was that some of the
department paper records for a period of a few months
were lost when one of the two study hospitals moved to
a new location, while the other was not in possession
of some of their records from one of the six years being
studied. Therefore, the ability to cross-check information
from the department records with OZ was impacted,
leading to possible missed identification of infants with
risk factors for hearing loss, and potentially influencing the
screening fail rate that was obtained.
Future Directions
In this study, seven CFA sub-groups were described based
on the anomalies present in the infants at the two study
hospitals. Development of a standardized list of specific
CFAs and their associated NBHS fail rates is needed to
maintain consistency across and, in turn, guide NBHS
programs in the United States. Because the findings in
this study were obtained from only two hospitals, a larger
scale study would provide information that could facilitate
the development of policies to address the specific hearing
needs of different sub-groups of the CFA group.
Having described NBHS fail rates in infants with different
CFAs in this paper, future research should focus on
describing the degree and type of hearing loss associated
with this population. Because specific diagnostic audiology
outcomes are not reported in OZ, we were unable to
obtain and analyze this information. Collaboration with
diagnostic testing facilities would allow access to this data.
In addition, it would be beneficial for NBHS programs to
document the specific diagnostic outcomes for infants who
are diagnosed with a hearing loss in their state database.
Such information would be beneficial for the medical
home, as well as audiologists, as it would help guide
appropriate monitoring and intervention.
Further research should aim to gather information about
how risk factor information is being entered and stored into
the various databases from a larger proportion of states.
In addition, future studies should also examine how NBHS
sites are conducting their screening protocols (such as a
one-step versus two-step screening approach as used in
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the two hospitals in this study), as that may influence the
pass/fail rate. The protocol that NBHS sites use as a pass/
fail criteria should be looked at as well. Getting all of this
information would help determine areas of weakness in
NBHS policy. This would help result in solutions that could
be universally applied to guide policy making, such as
ensuring accurate entry of information (e.g., for CFA and
its specific subtypes).
In the current study, 17.41% (n = 51) of infants who failed
the NBHS were lost to follow-up. This rate is less than
the national average of 31.3% (Subbiah et. al., 2018),
presumably due to audiology oversight of the NBHS
programs described in this paper. There have been studies
that explore reasons for loss to follow-up in newborn
hearing screening programs (ASHA, 2008), however,
there are no specific protocols in place for guiding
these programs. It is important to better understand the
underlying causes of loss-to follow-up rates so that JCIH
can make recommendations and guidelines for improving
service to infants and families.
Conclusions
Results from this study revealed that children with
CFAs were six times more likely to fail their NBHS
when compared to the fail rate for all infants at the two
participating hospitals.
Audiological follow-up and monitoring is not warranted for
infants with preauricular sinuses and tags unless the infant
exhibits other features associated with a syndrome that
has an associated risk for hearing loss. It is important to
document these anomalies in the state EHDI database so
that the medical home can monitor for any additional signs
and/or symptoms associated with such syndromes and
make appropriate referrals to other medical professionals.
Because the NBHS fail rates in this study varied greatly for
the different CFAs, further research should be completed
to determine if these findings can be replicated. If so, JCIH
should consider updating the list of risk factors for hearing
loss to delineate the current CFA category into different
subgroups. Along with updating the list of risk factors.
JCIH should also consider updating the recommendations
for each specific CFA, as infants in this risk factor group
should be followed based on their specific anomaly rather
than the group as a whole.
Results from the two surveys in this study demonstrate
that NBHS programs are not recording and documenting
risk factor information adequately and consistently. If
our findings are representative of the other state EDHI
programs that did not respond to the survey, this would
suggest a need for changes to the existing NBHS
protocol to include programs that train staff to identify
and document risk factors for hearing loss. This training
would improve the chances that risk factors for hearing
loss are being identified and properly documented. Correct
documentation of risk factors would also provide medical
professionals the information they need to appropriately
refer infants for follow-up evaluations, monitoring, and
early intervention services so that they have the best

opportunity to maximize their potential. This is imperative
because, without appropriate and timely referrals, children
are more likely to fall behind their hearing peers in
communication, cognition, reading, and social-emotional
development (JCIH, 2007).
Lastly, it would be advantageous to change the NBHS
guidelines to protocols to ensure consistency across all
programs. It is crucial that all NBHS programs throughout
the country follow the same procedures to improve
recommendations for follow-up care in a timely manner.
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Appendix A
EHDI State Leader Survey
1) If you agree with the informed consent above, please add a signature.
2) Which state do you represent?
3) Does your state mandate newborn hearing screenings in all, or most, birthing facilities?
a) Yes
b) No
4) Do facilities in your state submit newborn hearing screening data for infants born at that facility?
a) Yes, most facilities do
b) Some facilities do, some facilities do not
c) No, most facilities do not
5) If an infant is identified with a specific risk factor associated with childhood hearing loss including: family history
of hearing loss, NICU stay of greater than 5 days, hyperbilirubinemia with exchange transfusion, ototoxic
medications for greater than 5 days, asphyxia or hypoxic ischemic encephalopathy, ECMO, in-utero infections,
craniofacial anomalies, syndromes associated with hearing loss, and significant head trauma (re: JCIH 2019 Risk
Factor Indicators), are facilities in your state required to document this information in the state EHDI database?
a) Yes
b) No
6) Do facilities in your state submit this documentation, as required (re: question 5)?
a) Yes, most facilities do
b) Some facilities do, some facilities do not
c) No, most facilities do not
7) If an infant is identified as having a craniofacial anomaly, do facilities in your state record the specific anomaly
present (e.g., cleft lip and palate, preauricular sinus and tags, microtia, atresia, and/or syndromes such as
Trisomy 21, Treacher Collins syndrome, CHARGE Association, Crouzon disease, Klippel-Feil syndrome,
Goldenhar syndrome, Pierre Robin syndrome, etc.)?
a) Yes, most facilities do
b) Some facilities do, some facilities do not
c) No, most facilities do not
8) If a craniofacial anomaly risk factor is reported, but the specific anomaly is not recorded, do you request additional
information from the program coordinator about the specific craniofacial anomaly?
a) Yes
b) No
9) Are you satisfied with the documentation completed by the facilities in your state regarding the risk factors for
hearing loss?
a) Yes
b) No
10) Do you have any suggestions for how to improve the recording, reporting or follow-up process for infants with risk
factors for hearing loss, including infants with craniofacial anomalies?
11) Would you like the final results of the study sent to you?
a) Yes, electronically
b) Yes, via mail
c) No
12) If ‘yes’, where should the results be sent? (email address or mail address)
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Appendix B
Newborn Hearing Screening Program Coordinator Survey
1) If you agree with the informed consent above, please add a signature.
2) What is your profession?
3) In which state is your facility located?
4) Who performs the newborn hearing screenings? (Mark all that apply)
a)
b)
c)
d)

Audiologists
Nurses/Nurse Techs
Technicians hired specifically to perform the screenings
Other; please specify in the next question

5) If your answer was ‘other’ from the previous question, please specify.
6) If an audiologist does not perform the hearing screenings, does your facility employ an audiologist to oversee the
program?
a) Yes
b) No
c) N/A
7) Is your staff trained to identify the different risk factors associated with childhood hearing loss including: family
history of hearing loss, NICU stay of greater than 5 days, hyperbilirubinemia with exchange transfusion, ototoxic
medications for greater than 5 days, asphyxia or hypoxic ischemic encephalopathy, ECMO, in-utero infections,
craniofacial anomalies, syndromes associated with hearing loss, and significant head trauma (re: JCIH 2019 Risk
Factor Indicators)?
a) Yes
b) No
8) Is information regarding risk factors for childhood hearing loss collected either prior to or following each newborn
hearing screening? (if no skip to question 14).
a) Yes
b) No
9) If yes (re: question 8), how is this information collected? (Mark all that apply)
a) Ask hospital staff about risk factors
b) Check infant’s medical records (e.g., admission reports, lab reports, physician, nurse and/or social worker
assessments, etc.)
c) Ask the mother case history questions at the time of the hearing screening
d) Other
10)

Does your program record the type of risk factor(s) in the hospital medical records (re: question 8)?
a) Yes
b) No

11)

If an infant is identified as having one of the risk factors (re: question 7), does your program report this
information to your state Early Hearing Detection and Identification (EHDI) program?
a) Yes
b) No

12)

If an infant is identified as having a craniofacial anomaly, does your program record the specific type of
craniofacial anomaly present (e.g., cleft lip and palate, preauricular sinus and tags, microtia, atresia, and/or
syndromes such as Trisomy 21, Treacher Collins syndrome, CHARGE Association, Crouzon disease, KlippelFeil syndrome, Goldenhar syndrome, Pierre Robin syndrome, etc.)?
a) Yes
b) No
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Appendix B (cont.)
13)

If you answered ‘yes’ for the previous question, do you report the specific craniofacial anomaly to the state
EHDI program?
a) Yes
b) No

14)

Do you feel that you are getting enough guidance from your state EHDI program on how to document and
report risk factors, including craniofacial anomalies?
a) Yes
b) No

15)

Are you able to access the newborn hearing screening pass/fail data for infants with craniofacial anomalies
tested at your facility?
a) Yes
b) No

16)

If you answered ‘yes’ for the previous question, what is the refer rate for these infants for the period of January
2017 through December 2019?

17)

Would you like the final results of the study sent to you?
a) Yes, electronically
b) Yes, via mail
c) No

18)

If ‘yes’, where should the results be sent? (email address or mail address)
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Appendix C
Table C1
Profession of Participating Newborn Hearing Screening
(NBHS) Program Coordinators
Profession

Total Percentage (n)

Audiologist

37.66% (29)

Nurse

54.44% (49)

Table C3
States Represented in the Newborn Hearing Screening
Program Coordinator Survey
Profession
Arkansas

Total Percentage (n)
2.22% (2)

California

1.11% (1)

District of Columbia

2.22% (2)

Illinois

1.11% (1)

NBHS Coordinator

4.44% (4)

Nurse Practitioner

1.11% (1)

Louisiana

1.11% (1)

Operations Coordinator

1.11% (1)

Maryland

12.22% (11)

Perinatal Safety Specialist

1.11% (1)

Michigan

36.67% (33)

Unit Secretary

1.11% (1)

Missouri

1.11% (1)

Practice Manager

1.11% (1)

North Carolina

1.11% (1)

Administrative Assistant

1.11% (1)

New Jersey

6.67% (6)

Hearing Technician

1.11% (1)

New York

3.33% (3)

Did Not Answer

1.11% (1)

Nevada

1.11% (1)

Ohio

5.55% (5)

Oregon

1.11% (1)

South Carolina

1.11% (1)

Tennessee

1.11% (1)

20/90 facilities

Virginia

5.55% (5)

Nurses

61/90 facilities

Blank Responses

1.11% (1)

Technicians (hired specifically for
the hearing screening)

25/90 facilities

Others: Physician assistants, nurse
practitioners, trained volunteers
and student interns

4/90 facilities

Table C2
Profession of Those Conducting NBHS
Professiona
Audiologists

Total Facilities

Nebraska

14.44% (13)

Note. NBHS= Newborn Hearing Screening
a
Some facilities employ multiple professionals to perform
the screenings.
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